Q4 2026 Aurora Cannabis Inc Earnings Call Transcript
Key Points
- Aurora Cannabis Inc (ACB) reported a net revenue increase of 11% to $321 million, surpassing their guidance by $8 million.
- The company achieved a 32% year-over-year growth in adjusted EBITDA, reaching $54 million.
- Aurora Cannabis Inc (ACB) ended the fiscal year with a strong balance sheet, holding $165 million in cash and cash equivalents with no debt.
- The acquisition of Safari Flower Co. is expected to enhance Aurora's EU GMP capacity and contribute positively to adjusted EBITDA in fiscal year 2027.
- Aurora Cannabis Inc (ACB) expanded its medical cannabis portfolio across Canada, Europe, Australia, and New Zealand, reinforcing its leadership in regulated international markets.
- The company anticipates a 30% reduction in reimbursement rates for Canadian medical cannabis, impacting revenue and gross margins in fiscal year 2027.
- Aurora Cannabis Inc (ACB) is exiting the lower-margin Canadian consumer segment, which will result in a decline in total net revenue.
- Adjusted SG&A expenses increased due to expected credit losses and inflation-related labor costs.
- The fiscal year 2027 is expected to be a reset year with lower annual adjusted EBITDA due to changes in Canadian medical reimbursement pricing.
- There is increased price pressure in the German market, particularly in the value segment, which could impact future profitability.
Greetings and welcome to the Aurora Cannabis fiscal-year and fourth-quarter 2026 results conference call. (Operator Instructions) This conference call is being recorded today, Thursday, June 11, 2026.
I would now like to turn the conference over to your host, Kevin Niland, Senior Director of Strategic Finance and Investor Relations. Please go ahead, sir.
Hello, and thank you for joining us. With me is Miguel Martin, Chief Executive Officer, and Simona King, Chief Financial Officer. Earlier this morning, we filed our fiscal year and fourth quarter 2026 financials for the period ended March 31, 2026, and issued a news release containing both our annual and quarterly results. Our financial statements, MD&A, and news release are available on our IR website. They can also be accessed via SEDAR+ and EDGAR. In addition, you will find a supplemental information deck on our IR website.
Our discussion today serves as a reminder that certain matters could
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
